isoproterenol has been researched along with Extrasystole, Ventricular in 33 studies
Isoproterenol: Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on the heart, bronchi, skeletal muscle, alimentary tract, etc. It is used mainly as bronchodilator and heart stimulant.
isoprenaline : A secondary amino compound that is noradrenaline in which one of the hydrogens attached to the nitrogen is replaced by an isopropyl group. A sympathomimetic acting almost exclusively on beta-adrenergic receptors, it is used (mainly as the hydrochloride salt) as a bronghodilator and heart stimulant for the management of a variety of cardiac disorders.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To compare the arrhythmic response to isoproterenol and exercise testing in newly diagnosed arrhythmogenic right ventricular cardiomyopathy (ARVC) patients." | 7.88 | Arrhythmogenic response to isoproterenol testing vs. exercise testing in arrhythmogenic right ventricular cardiomyopathy patients. ( Cheniti, G; Cochet, H; Denis, A; Derval, N; Douard, H; Duchateau, J; Frontera, A; Haïssaguerre, M; Hocini, M; Jaïs, P; Kitamura, T; Lim, HS; Martin, C; Martin, R; Massoullie, G; Pambrun, T; Pillois, X; Sacher, F; Takigawa, M; Vlachos, K, 2018) |
| "Isoproterenol testing was performed with continuous infusion of isoproterenol (45 μg/min) for 3 minutes." | 5.40 | Diagnostic value of isoproterenol testing in arrhythmogenic right ventricular cardiomyopathy. ( Amraoui, S; Bordachar, P; Cochet, H; Daly, M; Denis, A; Derval, N; Haïssaguerre, M; Hocini, M; Jaïs, P; Komatsu, Y; Lim, HS; Pillois, X; Ploux, S; Ramoul, K; Ritter, P; Sacher, F; Shah, AJ; Zemmoura, A, 2014) |
| "To compare the arrhythmic response to isoproterenol and exercise testing in newly diagnosed arrhythmogenic right ventricular cardiomyopathy (ARVC) patients." | 3.88 | Arrhythmogenic response to isoproterenol testing vs. exercise testing in arrhythmogenic right ventricular cardiomyopathy patients. ( Cheniti, G; Cochet, H; Denis, A; Derval, N; Douard, H; Duchateau, J; Frontera, A; Haïssaguerre, M; Hocini, M; Jaïs, P; Kitamura, T; Lim, HS; Martin, C; Martin, R; Massoullie, G; Pambrun, T; Pillois, X; Sacher, F; Takigawa, M; Vlachos, K, 2018) |
| " During the tilt table test on isoproterenol, the patient developed ventricular fibrillation which was corrected immediately by cardioversion." | 3.70 | Significant complications can occur with ischemic heart disease and tilt table testing. ( Clarke, E; Gillette, P; Leman, RB, 1999) |
| "Isoproterenol was used as a surrogate for adrenergic stimulation both in vivo and in cardiomyocytes." | 1.62 | Discrete sites of frequent premature ventricular complexes cluster within the infarct border zone and coincide with high frequency of delayed afterdepolarizations under adrenergic stimulation. ( Amoni, M; Claus, P; De Buck, S; Dries, E; Ingelaere, S; Nagaraju, C; Roderick, HL; Sipido, KR; Vandenberk, B; Vermoortele, D; Willems, R, 2021) |
| "Paucity of a premature ventricular complex (PVC) during ablation procedures may occur and be associated with a lower success rate." | 1.56 | Stepwise approach to induce infrequent premature ventricular complex using bolus isoproterenol and epinephrine infusion. ( Aonuma, K; Ieda, M; Igarashi, M; Komatsu, Y; Nogami, A; Sekiguchi, Y; Shinoda, Y; Yamasaki, H, 2020) |
| "Isoproterenol testing was performed with continuous infusion of isoproterenol (45 μg/min) for 3 minutes." | 1.40 | Diagnostic value of isoproterenol testing in arrhythmogenic right ventricular cardiomyopathy. ( Amraoui, S; Bordachar, P; Cochet, H; Daly, M; Denis, A; Derval, N; Haïssaguerre, M; Hocini, M; Jaïs, P; Komatsu, Y; Lim, HS; Pillois, X; Ploux, S; Ramoul, K; Ritter, P; Sacher, F; Shah, AJ; Zemmoura, A, 2014) |
| "We hypothesized that VT in arrhythmogenic right ventricular dysplasia/cardiomyopathy shows a high degree of association with the PVC at baseline." | 1.39 | High prevalence of catecholamine-facilitated focal ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. ( Bhonsale, A; Calkins, H; James, C; Laurita, KR; Madhavan, S; Murray, B; Nazarian, S; Needleman, M; Philips, B; Tandri, H; Tichnell, C, 2013) |
| "Catecholaminergic polymorphic ventricular tachycardia (CPVT) is caused by mutations in cardiac ryanodine receptor (RyR2) or calsequestrin (Casq2) genes." | 1.39 | Accelerated sinus rhythm prevents catecholaminergic polymorphic ventricular tachycardia in mice and in patients. ( Faggioni, M; Hwang, HS; Kannankeril, PJ; Knollmann, BC; Nederend, I; van der Werf, C; Wilde, AA, 2013) |
| "Multiform premature ventricular complexes initiated the episodes of VF." | 1.38 | Characteristics of J wave-associated idiopathic ventricular fibrillation: role of drugs. ( Aizawa, Y; Chinushi, M; Furushima, H; Hasegawa, K; Iijima, K; Izumi, D; Sato, A, 2012) |
| "We describe a 71-year-old man with a ventricular tachycardia (VT) originating from the mitral annulus." | 1.33 | Idiopathic ventricular tachycardia originating from the posteroseptal mitral annulus: a case report. ( Ashikaga, K; Tashiro, H; Tsuchiya, T; Yamamoto, K, 2006) |
| "Recurrent ventricular fibrillation was initiated by short-coupled isolated monomorphic ventricular premature beats probably originating from the right ventricular outflow tract, associated with a manifest electrocardiographic pattern of Brugada syndrome." | 1.32 | Electrical storm in Brugada syndrome successfully treated using isoprenaline. ( Boveda, S; Brugada, J; Couderc, P; Delay, M; Maury, P, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (6.06) | 18.2507 |
| 2000's | 12 (36.36) | 29.6817 |
| 2010's | 14 (42.42) | 24.3611 |
| 2020's | 5 (15.15) | 2.80 |
| Authors | Studies |
|---|---|
| Aras, K | 1 |
| Gams, A | 1 |
| Faye, NR | 1 |
| Brennan, J | 1 |
| Goldrick, K | 1 |
| Li, J | 1 |
| Zhong, Y | 1 |
| Chiang, CH | 1 |
| Smith, EH | 1 |
| Poston, MD | 1 |
| Chivers, J | 1 |
| Hanna, P | 1 |
| Mori, S | 1 |
| Ajijola, OA | 1 |
| Shivkumar, K | 1 |
| Hoover, DB | 1 |
| Viventi, J | 1 |
| Rogers, JA | 1 |
| Bernus, O | 1 |
| Efimov, IR | 1 |
| Charafeddine, F | 1 |
| Refaat, MM | 1 |
| Shinoda, Y | 1 |
| Komatsu, Y | 2 |
| Nogami, A | 2 |
| Igarashi, M | 1 |
| Yamasaki, H | 1 |
| Sekiguchi, Y | 1 |
| Aonuma, K | 1 |
| Ieda, M | 2 |
| Hasebe, H | 1 |
| Yoshida, K | 1 |
| Furuyashiki, Y | 1 |
| Amoni, M | 1 |
| Claus, P | 1 |
| Dries, E | 1 |
| Nagaraju, C | 1 |
| De Buck, S | 1 |
| Vandenberk, B | 1 |
| Ingelaere, S | 1 |
| Vermoortele, D | 1 |
| Roderick, HL | 1 |
| Sipido, KR | 1 |
| Willems, R | 1 |
| Li, G | 1 |
| Wang, J | 1 |
| Liao, P | 1 |
| Bartels, P | 1 |
| Zhang, H | 1 |
| Yu, D | 1 |
| Liang, MC | 1 |
| Poh, KK | 1 |
| Yu, CY | 1 |
| Jiang, F | 1 |
| Yong, TF | 1 |
| Wong, YP | 1 |
| Hu, Z | 1 |
| Huang, H | 1 |
| Zhang, G | 1 |
| Galupo, MJ | 1 |
| Bian, JS | 1 |
| Ponniah, S | 1 |
| Trasti, SL | 1 |
| See, K | 1 |
| Foo, R | 1 |
| Hoppe, UC | 1 |
| Herzig, S | 1 |
| Soong, TW | 1 |
| Badertscher, P | 1 |
| Kuehne, M | 1 |
| Schaer, B | 1 |
| Sticherling, C | 1 |
| Osswald, S | 1 |
| Reichlin, T | 1 |
| Denis, A | 2 |
| Sacher, F | 2 |
| Derval, N | 2 |
| Martin, R | 1 |
| Lim, HS | 2 |
| Pambrun, T | 1 |
| Massoullie, G | 1 |
| Duchateau, J | 1 |
| Cochet, H | 2 |
| Pillois, X | 2 |
| Cheniti, G | 1 |
| Frontera, A | 1 |
| Takigawa, M | 1 |
| Vlachos, K | 1 |
| Martin, C | 1 |
| Kitamura, T | 1 |
| Hocini, M | 2 |
| Douard, H | 1 |
| Jaïs, P | 2 |
| Haïssaguerre, M | 2 |
| Wang, Y | 1 |
| Patel, D | 1 |
| Wang, DW | 2 |
| Yan, JT | 1 |
| Hsia, HH | 1 |
| Liu, H | 1 |
| Zhao, CX | 1 |
| Zuo, HJ | 1 |
| Shah, AJ | 1 |
| Daly, M | 1 |
| Ramoul, K | 1 |
| Zemmoura, A | 1 |
| Amraoui, S | 1 |
| Ritter, P | 1 |
| Ploux, S | 1 |
| Bordachar, P | 1 |
| Huang, X | 1 |
| Kim, TY | 1 |
| Koren, G | 1 |
| Choi, BR | 1 |
| Qu, Z | 1 |
| Rivas, N | 1 |
| Dhruvakumar, S | 1 |
| Mainigi, SK | 1 |
| Smith, T | 1 |
| Gerstenfeld, EP | 1 |
| Marchlinski, FE | 1 |
| Jastrzebski, M | 1 |
| Yamada, T | 1 |
| Plumb, VJ | 1 |
| Osorio, J | 1 |
| McElderry, HT | 1 |
| Doppalapudi, H | 1 |
| Kay, GN | 1 |
| Chinushi, M | 2 |
| Hasegawa, K | 1 |
| Iijima, K | 2 |
| Furushima, H | 2 |
| Izumi, D | 1 |
| Sato, A | 2 |
| Aizawa, Y | 1 |
| Jia, L | 1 |
| Yue-Chun, L | 1 |
| Kang-Ting, J | 1 |
| Na-Dan, Z | 1 |
| Jia-Xuan, L | 1 |
| Wen-Wu, Z | 1 |
| Peng-Lin, Y | 1 |
| Ji-Fei, T | 1 |
| Jia-Feng, L | 1 |
| Díaz Infante, E | 1 |
| Cózar León, R | 1 |
| Borrego, I | 1 |
| Maldonado, J | 1 |
| Nieto, P | 1 |
| Cruz Fernández, JM | 1 |
| Ashikaga, K | 1 |
| Tsuchiya, T | 1 |
| Tashiro, H | 1 |
| Yamamoto, K | 1 |
| Petric, S | 1 |
| Clasen, L | 1 |
| van Wessel, C | 1 |
| Geduldig, N | 1 |
| Ding, Z | 1 |
| Schullenberg, M | 1 |
| Mersmann, J | 1 |
| Zacharowski, K | 1 |
| Aller, MI | 1 |
| Schmidt, KG | 1 |
| Donner, BC | 1 |
| Philips, B | 1 |
| Madhavan, S | 1 |
| James, C | 1 |
| Tichnell, C | 1 |
| Murray, B | 1 |
| Needleman, M | 1 |
| Bhonsale, A | 1 |
| Nazarian, S | 1 |
| Laurita, KR | 2 |
| Calkins, H | 1 |
| Tandri, H | 1 |
| Faggioni, M | 1 |
| Hwang, HS | 1 |
| van der Werf, C | 1 |
| Nederend, I | 1 |
| Kannankeril, PJ | 2 |
| Wilde, AA | 1 |
| Knollmann, BC | 2 |
| Obreztchikova, MN | 1 |
| Sosunov, EA | 1 |
| Anyukhovsky, EP | 1 |
| Moïse, NS | 1 |
| Robinson, RB | 1 |
| Rosen, MR | 1 |
| Miller, D | 1 |
| Li, P | 1 |
| Armstrong, WF | 1 |
| Maury, P | 1 |
| Couderc, P | 1 |
| Delay, M | 1 |
| Boveda, S | 1 |
| Brugada, J | 1 |
| Katra, RP | 1 |
| Nam, GB | 1 |
| Burashnikov, A | 1 |
| Antzelevitch, C | 1 |
| Chopra, N | 1 |
| Yang, T | 1 |
| Hlaing, T | 1 |
| Holinstat, I | 1 |
| Ettensohn, K | 1 |
| Pfeifer, K | 1 |
| Akin, B | 1 |
| Jones, LR | 1 |
| Franzini-Armstrong, C | 1 |
| Shannon, TR | 1 |
| Li, H | 1 |
| Easley, A | 1 |
| Windle, J | 1 |
| Leman, RB | 1 |
| Clarke, E | 1 |
| Gillette, P | 1 |
| Liu, YB | 1 |
| Chen, WJ | 1 |
| Lee, YT | 1 |
| Kobayashi, Y | 1 |
| Yazawa, T | 1 |
| Adachi, T | 1 |
| Kawamura, M | 1 |
| Ryu, S | 1 |
| Asano, T | 1 |
| Obara, C | 1 |
| Katagiri, T | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Multi-center, Controlled Trial to Compare the Feasibility, Safety and Efficacy of Zero-fluoroscopic Approach With Fluoroscopic Approach for the Ablation of Paroxysmal Supraventricular Tachycardia[NCT03042078] | 3,060 participants (Actual) | Interventional | 2012-01-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for isoproterenol and Extrasystole, Ventricular
| Article | Year |
|---|---|
Oral caffeine intake amplifies the effect of isoproterenol in patients with frequent premature ventricular contractions.
Topics: Adult; Aged; Caffeine; Catheter Ablation; Humans; Isoproterenol; Male; Middle Aged; Ventricular Prem | 2020 |
32 other studies available for isoproterenol and Extrasystole, Ventricular
| Article | Year |
|---|---|
Electrophysiology and Arrhythmogenesis in the Human Right Ventricular Outflow Tract.
Topics: Acetylcholine; Adrenergic Agents; Cardiac Electrophysiology; Cholinergic Agents; Electrocardiography | 2022 |
Approach to induce infrequent premature ventricular complexes.
Topics: Epinephrine; Humans; Isoproterenol; Ventricular Premature Complexes | 2020 |
Stepwise approach to induce infrequent premature ventricular complex using bolus isoproterenol and epinephrine infusion.
Topics: Catheter Ablation; Coronary Angiography; Echocardiography; Electrocardiography; Epinephrine; Female; | 2020 |
Discrete sites of frequent premature ventricular complexes cluster within the infarct border zone and coincide with high frequency of delayed afterdepolarizations under adrenergic stimulation.
Topics: Animals; Disease Models, Animal; Epicardial Mapping; Isoproterenol; Magnetic Resonance Imaging, Cine | 2021 |
Exclusion of alternative exon 33 of Ca
Topics: Action Potentials; Alternative Splicing; Animals; Calcium Channel Blockers; Calcium Channels, L-Type | 2017 |
Case report: electrical storm during induced hypothermia in a patient with early repolarization.
Topics: Adrenergic beta-Agonists; Adult; Electrocardiography; Heart Arrest; Humans; Hypothermia, Induced; Is | 2017 |
Arrhythmogenic response to isoproterenol testing vs. exercise testing in arrhythmogenic right ventricular cardiomyopathy patients.
Topics: Action Potentials; Adrenergic beta-Agonists; Adult; Arrhythmogenic Right Ventricular Dysplasia; Case | 2018 |
β1-Adrenoceptor blocker aggravated ventricular arrhythmia.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Agonists; Adult; Aminophylline; Female; Huma | 2013 |
Diagnostic value of isoproterenol testing in arrhythmogenic right ventricular cardiomyopathy.
Topics: Adrenergic beta-Agonists; Adult; Arrhythmogenic Right Ventricular Dysplasia; Early Diagnosis; Electr | 2014 |
Spontaneous initiation of premature ventricular complexes and arrhythmias in type 2 long QT syndrome.
Topics: Adrenergic beta-Agonists; Animals; Animals, Genetically Modified; Arrhythmias, Cardiac; Calcium; Com | 2016 |
Ventricular premature depolarizations triggered by incremental dose isoproterenol infusion: common electrocardiographic features.
Topics: Adult; Cardiotonic Agents; Dose-Response Relationship, Drug; Electrocardiography; Female; Humans; Is | 2009 |
Double fire or junctional ectopy?
Topics: Cardiotonic Agents; Diagnosis, Differential; Electrocardiography; Humans; Isoproterenol; Tachycardia | 2009 |
A regular narrow QRS complex tachycardia with alternating atrial activation sequences within the coronary sinus: what is the mechanism?
Topics: Adenosine; Adult; Catheter Ablation; Female; Humans; Isoproterenol; Tachycardia, Supraventricular; V | 2010 |
Characteristics of J wave-associated idiopathic ventricular fibrillation: role of drugs.
Topics: Anti-Arrhythmia Agents; Cardiotonic Agents; Defibrillators, Implantable; Humans; Isoproterenol; Male | 2012 |
Premature ventricular contractions originating from the left ventricular septum: results of radiofrequency catheter ablation in twenty patients.
Topics: Action Potentials; Adolescent; Adrenergic beta-Agonists; Adult; Aged; Body Surface Potential Mapping | 2011 |
[Ablation of premature ventricular contractions originating in the right ventricular outflow tract using non-contact mapping].
Topics: Adrenergic beta-Agonists; Adult; Anti-Arrhythmia Agents; Catheter Ablation; Electrocardiography; Ele | 2011 |
Idiopathic ventricular tachycardia originating from the posteroseptal mitral annulus: a case report.
Topics: Adenosine Triphosphate; Aged; Cardiotonic Agents; Catheter Ablation; Cyclic AMP; Exercise; Humans; I | 2006 |
In vivo electrophysiological characterization of TASK-1 deficient mice.
Topics: Adrenergic beta-Agonists; Anesthetics; Animals; Atrial Function; Baroreflex; Electric Stimulation; E | 2012 |
High prevalence of catecholamine-facilitated focal ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy.
Topics: Adolescent; Adrenergic beta-Agonists; Adult; Aged; Arrhythmogenic Right Ventricular Dysplasia; Balti | 2013 |
Accelerated sinus rhythm prevents catecholaminergic polymorphic ventricular tachycardia in mice and in patients.
Topics: Adult; Animals; Atropine; Bradycardia; Caffeine; Calcium Signaling; Calsequestrin; Cardiac Pacing, A | 2013 |
Short-coupling premature ventricular complexes from the left ventricle triggered isoproterenol-resistant electrical storm in a patient with Brugada syndrome.
Topics: Adult; Anti-Arrhythmia Agents; Bepridil; Brugada Syndrome; Cardiotonic Agents; Electrocardiography; | 2013 |
Heterogeneous ventricular repolarization provides a substrate for arrhythmias in a German shepherd model of spontaneous arrhythmic death.
Topics: Action Potentials; Animals; Cells, Cultured; Death, Sudden, Cardiac; Dogs; Electric Conductivity; He | 2003 |
The effect of time and of vasoactive drugs on capillary leakage induced during myocardial contrast echocardiography.
Topics: Animals; Bronchodilator Agents; Capillary Fragility; Coloring Agents; Contrast Media; Echocardiograp | 2004 |
Electrical storm in Brugada syndrome successfully treated using isoprenaline.
Topics: Adrenergic beta-Agonists; Adult; Bundle-Branch Block; Defibrillators, Implantable; Electrocardiograp | 2004 |
Cellular mechanism of calcium-mediated triggered activity in the heart.
Topics: Action Potentials; Adrenergic beta-Agonists; Animals; Calcium; Calcium Channels; Calcium Signaling; | 2005 |
Cellular mechanisms underlying the development of catecholaminergic ventricular tachycardia.
Topics: Action Potentials; Animals; Caffeine; Calcium; Catecholamines; Disease Models, Animal; Dogs; Dose-Re | 2005 |
Modest reductions of cardiac calsequestrin increase sarcoplasmic reticulum Ca2+ leak independent of luminal Ca2+ and trigger ventricular arrhythmias in mice.
Topics: Animals; Calbindin 2; Calcium; Calcium Channels; Calcium Signaling; Calsequestrin; Cardiac Pacing, A | 2007 |
Linking calsequestrin to lumenal control of SR Ca2+ release.
Topics: Animals; Calbindin 2; Calcium; Calcium Channels; Calcium Signaling; Calsequestrin; Cardiac Pacing, A | 2007 |
Problematic palpitations and exercise induced preexcitation.
Topics: Adenosine; Adult; Anti-Arrhythmia Agents; Bundle of His; Cardiac Pacing, Artificial; Cardiotonic Age | 1997 |
Significant complications can occur with ischemic heart disease and tilt table testing.
Topics: Adrenergic beta-Agonists; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Bundle-Branch Blo | 1999 |
Apparent ventricular bigeminy in the congenital long QT syndrome: what is the mechanism?
Topics: Action Potentials; Adrenergic beta-Agonists; Adult; Diagnosis, Differential; Electrocardiography; Fe | 2000 |
Ventricular arrhythmias with left bundle branch block pattern and inferior axis: assessment of their mechanisms on the basis of response to ATP, nicorandil and verapamil.
Topics: Adenosine Triphosphate; Adult; Anti-Arrhythmia Agents; Biological Transport, Active; Bundle-Branch B | 2000 |